4.6 Article

Regulation of the tumor suppressor PML by post-translational modifications

Journal

FRONTIERS IN ONCOLOGY
Volume 2, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2012.00204

Keywords

promyelocytic leukemia; PML-RAR alpha; post-translational modifications; protein kinases; ubiquitin E3 ligases

Categories

Funding

  1. German Research Foundation [SCHM 1417/7-1, SCHM 1417/8-1, SCHM1417/9-1, SFB/TRR 81]
  2. PROMISE [IRTG1566]
  3. German Academic Exchange Service [A/08/98404, A/11/90192]

Ask authors/readers for more resources

Post-translat onal modifications (PTMs) regulate multiple biological functions of the promyelocytic leukemia (PML) protein and also the fission, disassembly, and rebuilding of PML nuclear bodies (PML-NBs) during the cell cycle. Pathway-specific PML modification patterns ensure proper signal output from PML-NBs that suit the specific functional requirements. Here we comprehensively review the signaling pathways and enzymes that modify PML and also the oncogenic PML-RAR alpha fusion protein. Many PTMs occur in a hierarchical and timely organized fashion. Phosphorylation or acetylation constitutes typical starting points for many PML modifying events, while degradative ubiquitination is an irreversible end point of the modification cascade. As this hierarchical organization of PTMs frequently turns phosphorylation events as primordial events, kinases or phosphatases regulating PML phosphorylation may be interesting drug targets to manipulate the downstream modifications and thus the stability and function of PML or PML-RAR alpha.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available